
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
JNJ | NYSE | USD | Real-time | |
JNJ | Mexico | MXN | Delayed | |
JNJ | TradeGate | EUR | Delayed | |
JNJ | Frankfurt | EUR | Delayed | |
JNJ | Xetra | EUR | Delayed | |
JNJ | Buenos Aires | ARS | Delayed | |
DJNJ2 | Buenos Aires | ARS | Delayed | |
JNJB34 | BM&FBovespa | BRL | Delayed | |
JNJ | Vienna | EUR | Delayed | |
JNJ_KZ | KASE | USD | Delayed | |
JNJ | Colombia | COP | Delayed | |
JNJ | Lima | USD | Delayed |
Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.
Name | Age | Since | Title |
---|---|---|---|
Joaquin Duato | 60 | 2011 | CEO & Chairman |
Paula A. Johnson | 63 | 2023 | Independent Director |
Mark B. McClellan | 59 | 2013 | Independent Director |
Anne M. Mulcahy | 71 | 2009 | Lead Independent Director |
Marillyn A. Hewson | 69 | 2019 | Independent Director |
Jennifer A. Doudna | 59 | 2018 | Independent Director |
Mary C. Beckerle | 68 | 2015 | Independent Director |
Mark Alan Weinberger | 61 | 2019 | Independent Director |
D. Scott Davis | 71 | 2014 | Independent Director |
Darius E. Adamczyk | 57 | 2022 | Independent Director |
Hubert Joly | 64 | 2019 | Independent Director |
Nadja Y. West | 62 | 2020 | Independent Director |
Paula A. Johnson | 63 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review